학술논문
CD74/SLC34A2-ROS1 Fusion Variants Involving the Transmembrane Region Predict Poor Response to Crizotinib in NSCLC Independent of TP53 Mutations
Document Type
Article
Author
Source
In Journal of Thoracic Oncology April 2024 19(4):613-625
Subject
Language
ISSN
1556-0864